Anti-epiligrin cicatricial pemphigoid and relative risk for cancer
Authors:
- Conleth A EganCEConleth A Egan
- Zelmira LazarovaZLZelmira Lazarova
- Thomas N DarlingTDThomas N Darling
- Carole YeeCYCarole Yee
- Timothy CoteTCTimothy Cote
- Kim B YanceyKYKim B Yancey
- 1 June 2001
- journal article
- Published by Elsevier in The Lancet
- Vol. 357 (9271) , 1850-1851
Abstract
No abstract availableKeywords
This publication has 4 references indexed in Scilit:
- Pemphigoid: Clinical, Histologic, Immunopathologic, and Therapeutic ConsiderationsJAMA, 2000
- Human Anti-Laminin 5 Autoantibodies Induce Subepidermal Blisters in an Experimental Human Skin Graft ModelJournal of Investigative Dermatology, 2000
- Epiligrin, the major human keratinocyte integrin ligand, is a target in both an acquired autoimmune and an inherited subepidermal blistering skin disease.Journal of Clinical Investigation, 1992
- Bullous pemphigoid: the frequency of mucosal involvement and concurrent malignancy related to indirect immunofluorescence findingsBritish Journal of Dermatology, 1981